Advertisement
Viatris
Premium
General
30 April, 2024
Grapevine: CX Partners starts Veeda Clinical sale process; Ola CEO departs amid job cuts
CX Partners, a mid-market private equity firm, has started the process to divest its majority stake in Veeda Clinical Research, an ......
Premium
General
29 February, 2024
Grapevine: KKR mulls JB Pharma sale; Bharti eyes Del Monte JV exit
Private equity firm KKR & Co. is exploring options for a potential sale of its 53.8% controlling stake in Mumbai-based ......
Premium
Healthcare
11 July, 2022
Analysis: M&A deal value in healthcare and pharma hits record high in Jan-June
Merger and acquisitions (M&As) deal value in the healthcare and pharmaceutical space hit a record high in Jan-June, crossing the ......
Advertisement
Recommended for you
Advertisement